References
- Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics – 2012 update.Circulation doi:10.1161/CIR.0b013e31823ac046 (2012) (Epub ahead of print).
- Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res. 109(8), 923–940 (2011).
- Chen J, Zhang ZG, Li Y et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92(6), 692–699 (2003).
- Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39(3), 924–928 (2008).
- Mattle HP, Savitz SI. Advances in emerging therapies 2010. Stroke 42(2), 298–300 (2011).
- Savitz SI, Misra V, Kasam M et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann. Neurol. 70(1), 59–69 (2011).
- Honma T, Honmou O, Iihoshi S et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp. Neurol. 199(1), 56–66 (2006).
- Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood Flow Metab. 28(2), 329–340 (2008).
- Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med. 344(10), 710–719 (2001).
- Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 8(5), 491–500 (2009).
- Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25(9), 1794–1798 (1994).
- Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK. Intravascular cell replacement therapy for stroke. Neurosurg. Focus 24(3–4), e15 (2008).
- Ajmo CT Jr, Collier LA, Leonardo CC et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp. Neurol. 218(1), 47–55 (2009).
- Németh K, Leelahavanichkul A, Yuen PS et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15(1), 42–49 (2009).
- Moniche F, Gonzalez A, Gonzalez-Marcos JR et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43(8), 2242–2244 (2012).
- Friedrich MA, Martins MP, Araújo MD et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant. 21(Suppl. 1), S13–S21 (2012).
- Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57(6), 874–882 (2005).
- Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY; STARTING collaborators. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28(6),1099–1106 (2010).
- Honmou O, Houkin K, Matsunaga T et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6), 1790–1807 (2011).
- Bhasin A, Srivastava MV, Kumaran SS et al. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc. Dis. Extra 1(1), 93–104 (2011).